How much will Herceptin really cost?
- PMID: 17124225
- PMCID: PMC1661755
- DOI: 10.1136/bmj.39008.624051.BE
How much will Herceptin really cost?
Abstract
New guidance from the National Institute for Health and Clinical Excellence recommends Herceptin in early breast cancer, but it provides no additional funding or any suggestion of which services to cut. This leaves medical staff with difficult decisions to make
Conflict of interest statement
Competing interests: None declared.
Comment in
-
How much will Herceptin really cost? The money is already there.BMJ. 2006 Dec 9;333(7580):1219; discussion 1219-20. doi: 10.1136/bmj.39052.480231.FA. BMJ. 2006. PMID: 17158392 Free PMC article. No abstract available.
-
How much will Herceptin really cost? Balancing local and national priorities is not new.BMJ. 2006 Dec 9;333(7580):1219; discussion 1219-20. doi: 10.1136/bmj.39051.733715.3A. BMJ. 2006. PMID: 17158393 Free PMC article. No abstract available.
References
-
- Timmins N. Drugs and the NHS's £30 000 question. Financial Times 10 Aug 2001.
-
- National Institute for Health and Clinical Excellence. Trastuzumab for the treatment of early stage HER-2 positive breast cancer. Technology appraisal 107. London: NICE, 2006. http://www.nice.org.uk/page.aspx?o=TA107 (accessed 20 Oct 2006).
-
- National Institute for Health and Clinical Excellence. Guidance on the use of trastuzumab for the treatment of advanced breast cancer. Technology appraisal 34. London: NICE, 2002.
-
- Breast Clinical Studies Group. UK clinical guidelines for the use of adjuvant trastuzumab (Herceptin®) with or following chemotherapy in HER2-positive early breast cancer. London: National Cancer Research Institute, 2005. www.dh.gov.uk/assetRoot/04/12/63/84/04126384.pdf.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical